Twitter-1948397942349480245

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-24
Post ID
1948397942349480245

Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.​
​
Learn more about transitional pain: <a href="https://t.co/rbGp7fDgpa&quot; target="_blank">https://t.co/rbGp7fDgpa</a&gt;

Post video URL
https://video.twimg.com/ext_tw_video/1948397787969679360/pu/vid/avc1/320x570/WGR4yRKl8ZeeVxaX.mp4?tag=12
Post URL
https://t.co/zYRoBpB5gd
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:ugcPost:7354175450002178048

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1753372061
Post ID
urn:li:ugcPost:7354175450002178048

Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery at home, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.​
​
Learn more about transitional pain: <a href="https://bit.ly/3T0oKZ2&quot; target="_blank">https://bit.ly/3T0oKZ2</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>

Post video URL
https://dms.licdn.com/playlist/vid/v2/D5605AQHRlj77bAo6uA/mp4-720p-30fp-crf28/B56Zg9HmyZH0Bw-/0/1753372080662?e=1754434800&v=beta&t=D92v6L6GGbMNnQW6l5lBbEVSJ1PvnFmhzEZdvooK0Ec
Post URL
https://www.linkedin.com/feed/update/urn:li:ugcPost:7354175450002178048
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:ugcPost:7354163885341356032

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1753369304
Post ID
urn:li:ugcPost:7354163885341356032

Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery at home, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.​
​
Learn more about transitional pain: <a href="https://okt.to/jXbnRi&quot; target="_blank">https://okt.to/jXbnRi</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>

Post video URL
https://dms.licdn.com/playlist/vid/v2/D5610AQFzdqEB_w0VWg/mp4-720p-30fp-crf28/B56Zg88wcUHcB0-/0/1753369260254?e=1753977600&v=beta&t=CHP1nmtSiHCmS_nJp_StqpLH7tNNhMnz93233tkjzgE
Post URL
https://www.linkedin.com/feed/update/urn:li:ugcPost:7354163885341356032
Post creted timestamp

Twitter-1948035545008922752

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-23
Post ID
1948035545008922752

Individuals with symptomatic IST typically have heart rates greater than 100 bpm even with minimal activity. For those who don’t respond to medications, the HEAL-IST clinical trial is evaluating a new hybrid ablation procedure as a potential treatment.​ Learn more:

Post image URL
https://pbs.twimg.com/media/GwjQANWXcAETz9G.png
Post URL
https://t.co/gwQDXBLpcw
Post creted timestamp

Facebook-171059586426348_1340230991440038

Submitted by ryadav-admin on
Feed type
Facebook
Post created date
2025-07-23T15:00:37+0000
Post ID
171059586426348_1340230991440038

Individuals with symptomatic IST typically have heart rates greater than 100 beats per minute even with minimal activity. ​
​
The HEAL-IST Trial is currently enrolling patients to evaluate whether a hybrid sinus node sparing procedure is a safe and effective treatment option for symptomatic and drug-resistant IST patients.​

See candidate qualifications at: heal-ist.com <a href="https://www.facebook.com/hashtag/

IST" target="_blank">

#IST</a> <a href="https://www.facebook.com/hashtag/InnapropriateSinusTachycardia&quot; target="_blank">#InnapropriateSinusTachycardia</a> <a href="https://www.facebook.com/hashtag/ClinicalTrial&quot; target="_blank">#ClinicalTrial</a>

Post image URL
https://scontent-iad3-1.xx.fbcdn.net/v/t39.30808-6/521895844_1340230934773377_3668537340852190252_n.jpg?stp=dst-jpg_p720x720_tt6&_nc_cat=102&ccb=1-7&_nc_sid=127cfc&_nc_ohc=KXkCTCpg7VYQ7kNvwGPOTyJ&_nc_oc=AdmaEFcvFWgurkq7020-4zM469ygONjCqR65EuGC9TyW0E_EkqIQX7dic39Wkq0_KUU&_nc_zt=23&_nc_ht=scontent-iad3-1.xx&edm=AKIiGfEEAAAA&_nc_gid=VYYYBVCxRxFH4XsTiReFOw&oh=00_AfQXtwXf_14pAvX54xH6q-ooq3WVGHdEaGSZUkHOScodtw&oe=689216A1
Post URL
https://www.facebook.com/513124590817353/posts/1340230991440038
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:share:7353801146899050496

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1753282820
Post ID
urn:li:share:7353801146899050496

Individuals with symptomatic IST typically have heart rates greater than 100 beats per minute even with minimal activity. ​
​
The HEAL-IST Trial is currently enrolling patients to evaluate whether a hybrid sinus node sparing procedure is a safe and effective treatment option for symptomatic and drug-resistant IST patients.​
​
See candidate qualifications at: heal-ist.com ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=InappropriateSinusTachy…; target='_blank'>#InappropriateSinusTachycardia</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a>

Post image URL
https://media.licdn.com/dms/image/v2/D5610AQHZQi2VSrUU-Q/image-shrink_800/B56Zg3zKTsH0As-/0/1753282816879?e=1754625600&v=beta&t=BHNnkAnsYpaVBeeGsVqMQUuV5wCMAzhJ9LMDh-vm2p8
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7353801146899050496
Post creted timestamp

Twitter-1947673111186292832

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-22
Post ID
1947673111186292832

Backed by over a decade of clinical evidence, LAAE is a Class IA recommendation from AHA, ACC &amp; STS.​

The AtriClip® FLEX-Mini™ is the newest, lowest-profile device in our full LAAE portfolio—designed for gold-standard care.​
​
Learn more: <a href="https://t.co/JEybEUFTho&quot; target="_blank">https://t.co/JEybEUFTho</a&gt;

<a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Post image URL
https://pbs.twimg.com/media/GweGX1qWIAEa_Is.png
Post URL
https://t.co/07cvAx0TUS
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:share:7353439045131132929

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1753196488
Post ID
urn:li:share:7353439045131132929

Backed by over a decade of clinical evidence, left atrial appendage exclusion (LAAE) is a Class IA recommendation from the AHA, ACC and STS.​

The AtriClip® FLEX-Mini™ is the newest addition to our comprehensive portfolio of LAAE devices—offering our lowest-profile design yet.​

A full portfolio, built for gold-standard care.​

Learn more: <a href="https://okt.to/j9gRXK&quot; target="_blank">https://okt.to/j9gRXK</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAE&highlightedUpdateU…; target='_blank'>#LAAE</a>

Post image URL
https://media.licdn.com/dms/image/v2/D4D10AQFu3TDd2-yqiw/image-shrink_800/B4DZgypvkEGsAc-/0/1753196469722?e=1754406000&v=beta&t=gSwUF_iDW-ltN0THA8exbyQozM7YScS1zHL7s8XMjMw
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7353439045131132929
Post creted timestamp

Twitter-1947310750994673847

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-21
Post ID
1947310750994673847

Designed for patients with long-standing persistent Afib, the EPi-Sense ST™ System is the only FDA-approved device for minimally invasive ablation therapy to treat LSPAF.​

Discover how EPi-Sense ST™ is helping address the most undertreated Afib population:

Post image URL
https://pbs.twimg.com/media/GwY8znsW0AA3iCx.png
Post URL
https://t.co/jTCHPAMIcE
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:share:7353076323264720897

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1753110009
Post ID
urn:li:share:7353076323264720897

Designed for patients with long-standing persistent Afib, the EPi-Sense ST™ System is the only FDA-approved device for minimally invasive ablation therapy to treat LSPAF.​

Discover how EPi-Sense ST™ is helping address the most prevalent and undertreated Afib population: <a href="https://okt.to/TzXedu&quot; target="_blank">https://okt.to/TzXedu</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

Post image URL
https://media.licdn.com/dms/image/v2/D5610AQEkyz9rUftmPQ/image-shrink_800/B56Zgtf72hHQAc-/0/1753110005390?e=1754078400&v=beta&t=SpyukEi8LGE_-U9Cx4bXbWVpki36cZMqHEDlGycZAQg
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7353076323264720897
Post creted timestamp
Subscribe to
© 2025 Atricure, Inc. All Rights Reserved.